Biotherapeutics is a branch of learning which refers to the field encompassing therapeutic materials produced using biological means, including recombinant DNA technology.
The Biotherapeutics market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Biotherapeutics industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Biotherapeutics market can be split based on product types, major applications, and important countries as follows:
Key players in the global Biotherapeutics market covered in Chapter 12:
Catalent, Inc.
Lonza Group Ltd.
Selexis SA
SAFC
Thermo Fisher Scientific, Inc.
CMC Biologics
Boehringer Ingelheim Pharma GmbH & Co KG.
Beckman Coulter, Inc.
Partec
ProBioGen AG
In Chapter 4 and 14.1, on the basis of types, the Biotherapeutics market from 2015 to 2025 is primarily split into:
Transfection
Single cell cloning: manual limited dilution cloning, FACS, ClonePix and Others
In Chapter 5 and 14.2, on the basis of applications, the Biotherapeutics market from 2015 to 2025 covers:
Clinical treatment
Scientific research
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Biotherapeutics. Industry analysis & Market Report on Biotherapeutics is a syndicated market report, published as COVID-19 Outbreak-Global Biotherapeutics Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020. It is complete Research Study and Industry Analysis of Biotherapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.